Transforaminal interbody fusion and the "off label" use of recombinant human bone morphogenetic protein-2

Spine Journal

Volumn 9, Issue 8, 2009, Pages 667-669

  Vaidya, Rahul ^a  

^a DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BONE GRAFT; FOOD AND DRUG ADMINISTRATION; INTERVERTEBRAL DISK DEGENERATION; LUMBAR SPINE; OSSIFICATION; PEDICLE SCREW; PRIORITY JOURNAL; SPINE FUSION; SPINE SURGERY; TRANSFORAMINAL LUMBAR INTERBODY FUSION;

EID: 67651085493     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2009.05.014     Document Type: Note

References (27)

1. Harms J.G., and Rollinger H. A one-stage procedure in operative treatment of spondylolisthesis: dorsal traction-reposition and anterior fusion. Z Orthop Ihre Grenzeb 120 (1982) 343-347
2. DiPaola C.P., and Molinari R.W. Posterior lumbar interbody fusion. J Am Acad Ortho Surg 16 (2008) 130-139
3. Humphreys S.C., Hodges S.D., Patwardhan A.G., et al. Comparison of posterior and transforaminal approaches to lumbar interbody fusion. Spine 26 (2001) 567-571
4. Hackenberg L., Halm H., Bullmann V., et al. Transforaminal lumbar interbody fusion: a safe technique with satisfactory three to five year results. Eur Spine J 14 (2005) 551-558
5. Lauber S., Schulte T.L., Liljenqvist U., et al. Clinical and radiologic 2-4-year results of transforaminal lumbar interbody fusion in degenerative and isthmic spondylolisthesis grades 1 and 2. Spine 31 (2006) 1693-1698
6. Lowe T.G., and Tahernia A.D. Unilateral transforaminal posterior lumbar interbody fusion. Clin Orthop Relat Res 394 (2002) 64-72
7. Lowe T.G., Tahernia A.D., O'Brien M.F., and Smith D.A. Unilateral transforaminal posterior lumbar interbody fusion (TLIF): indications, technique, and 2-year results. J Spinal Disord Tech 15 (2002) 31-38
8. Urist M.R. Bone formation by autoinduction. Science 150 (1965) 893-899
9. Wang E.A., Rosen V., D'Alessandro J.S., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87 (1990) 2220-2224
10. Food and Drug Agency. Available at:. http://www.fda.gov/cdrh/pdf/P000058.html Accessed July 2, 2002
11. FDA Public Health Notification. Life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion. Available at:. http://www.personalinjurylawyeramerica.com/pdf/20080701-fda-infuse.pdf Accessed July 1, 2008
12. Miyazaki M., Tsumura H., Wang J.C., and Alanay A. An update on bone substitutes for spinal fusion. Eur Spine J 18 (2009) 783-799
13. Baskin D.S., Ryan P., Sonntag V., et al. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 28 (2003) 1219-1224
14. Mummaneni P.V., Pan J., Haid R.W., et al. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. J Neurosurg Spine 1 (2004) 19-23
15. Shields L.B., Raque G.H., Glassman S.D., et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31 (2006) 542-547
16. Vaidya R., Carp J., Sethi A., et al. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 16 (2007) 1257-1265
17. Meisel H.J., Schnöring M., Hohaus C., et al. Posterior lumbar interbody fusion using rhBMP-2. Eur Spine J 17 (2008) 1735-1744 Epub 2008 Oct 7
18. Pradhan B.B., Bae H.W., Dawson E.G., et al. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2. Spine 31 (2006) E277-E284
19. Burkus J.K., Sandhu H.S., Gornet M.F., and Longley M.C. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 87 (2005) 1205-1212
20. Lewandrowski K.U., Nanson C., and Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Spine J 7 (2007) 609-614
21. Hansen S.M., and Sasso R.C. Resorptive response of rhBMP2 simulating infection in an anterior lumbar interbody fusion with a femoral ring. J Spinal Disord Tech 19 (2006) 130-134
22. Vaidya R., Sethi A., Bartol S., et al. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 21 (2008) 557-562
23. Toth J.M., Boden S.D., Burkus J.K., et al. Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment. Spine 34 (2009) 539-550
24. Vaidya R., Weir R., Sethi A., et al. Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. J Bone Joint Surg Br 89 (2007) 342-345
25. Villavicencio A.T., Burneikiene S., Bulsara K.R., and Thramann J.J. Perioperative complications in transforaminal lumbar interbody fusion versus anterior-posterior reconstruction for lumbar disc degeneration and instability. J Spinal Disord Tech 19 (2006) 92-97
26. Joseph V., and Rampersaud Y.R. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Spine 32 (2007) 2885-2890
27. Rihn JA., Patel R., Makda J., et al. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J 9 (2009) 623-629